mifepristone has been researched along with Carcinoma, Hepatocellular in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Dong, H; Jia, L; Li, B; Liu, J; Liu, W; Nie, H; Wang, J; Zheng, N | 1 |
| Jin, ZJ; Li, YL; Li, YR; Wang, L; Zhang, HY | 1 |
| Liu, MC; Suiko, M; Yasuda, S | 1 |
| Marks, B; Raucy, J; Trubetskoy, O; Yueh, MF; Zielinski, T | 1 |
| Banks, M; Cacace, A; Connors, D; Dickinson, K; Herbst, J; Marino, A; O'Connell, J; Puglisi, J; Sinz, M; Stewart, J; Zhu, Z | 1 |
| Beck, G; Chasserot-Golaz, S; Venetianer, A | 1 |
| Auwerx, J; Fruchart, JC; Saladin, R; Staels, B; Vu-Dac, N | 1 |
| Itoh, N; Kasutani, K; Kimura, M; Muto, N; Otaki, N; Tanaka, K | 1 |
| Aggerbeck, M; Barouki, R; Lombès, M; Massaad, C; Rafestin-Oblin, ME | 1 |
| Chung, E; Huh, B; Lee, KY; Lee, SK; Lee, YH; Lee, YJ | 1 |
| Albertini, A; Di Lorenzo, D; Fenaroli, A; Ferrari, F; Rigaud, G; Savoldi, G | 1 |
| Coe, JE; Ishak, KG; Ross, MJ | 1 |
| Gibson, GG; Goldfarb, PS; Gray, TJ; Ogg, MS; Tarbit, M; Williams, JM | 1 |
13 other study(ies) available for mifepristone and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chemical Phenomena; Drug Compounding; Drug Resistance, Neoplasm; Female; Humans; Inhibitory Concentration 50; Liver Neoplasms; Mice; Mifepristone; Nanoparticles; Polyesters; Polyethylene Glycols; Protein Kinase Inhibitors; Receptors, CXCR4; Sorafenib; Xenograft Model Antitumor Assays | 2019 |
[Gene therapy based on inducible IL-12 gene in a mouse model of orthotopically transplanted H22 hepatoma].
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Female; Genetic Therapy; Humans; Interferon-gamma; Interleukin-12; Lac Operon; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mifepristone; Neoplasm Transplantation; Neovascularization, Pathologic; Nitric Oxide; Plasmids; Proliferating Cell Nuclear Antigen; Random Allocation | 2010 |
Oral contraceptives as substrates and inhibitors for human cytosolic SULTs.
Topics: Arylsulfotransferase; Carcinoma, Hepatocellular; Cell Line, Tumor; Contraceptives, Oral; Cytosol; Estradiol; Ethynodiol Diacetate; Humans; Kinetics; Mifepristone; Norethindrone; Norethindrone Acetate | 2005 |
A simultaneous assessment of CYP3A4 metabolism and induction in the DPX-2 cell line.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Chromans; Clotrimazole; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dexamethasone; Dimethyl Sulfoxide; Enhancer Elements, Genetic; Enzyme Induction; Genes, Reporter; Genes, Synthetic; Humans; Ketoconazole; Liver Neoplasms; Lovastatin; Luciferases; Mifepristone; Neoplasm Proteins; Nifedipine; Omeprazole; Paclitaxel; Phenytoin; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Recombinant Fusion Proteins; Rifampin; Thiazolidinediones; Transcription, Genetic; Troglitazone; Troleandomycin | 2005 |
Use of cryopreserved transiently transfected cells in high-throughput pregnane X receptor transactivation assay.
Topics: Biological Assay; Caco-2 Cells; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Membrane Permeability; Cryopreservation; Drug-Related Side Effects and Adverse Reactions; Humans; Liver Neoplasms; Mifepristone; Pharmaceutical Preparations; Pregnane X Receptor; Receptors, Steroid; Reproducibility of Results; Rifampin; Sulfinpyrazone; Transcriptional Activation; Transfection | 2007 |
Biotransformation of 17 beta-hydroxy-11 beta-(4-dimethylaminophenyl)17 alpha-1-propynyl-estra-4,9-dien-3-one (RU486) in rat hepatoma variants.
Topics: Animals; Carcinoma, Hepatocellular; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dexamethasone; Enzyme Induction; Mifepristone; Phenobarbital; Rats; Troleandomycin; Tumor Cells, Cultured | 1993 |
Transcriptional induction of rat liver apolipoprotein A-I gene expression by glucocorticoids requires the glucocorticoid receptor and a labile cell-specific protein.
Topics: Animals; Apolipoprotein A-I; Apolipoprotein A-II; Base Sequence; Carcinoma, Hepatocellular; Cell Line; Cell Nucleus; Cells, Cultured; Chloramphenicol O-Acetyltransferase; Chlorocebus aethiops; Cloning, Molecular; Dactinomycin; Dexamethasone; DNA Primers; Glucocorticoids; Kinetics; Liver; Male; Mifepristone; Molecular Sequence Data; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Recombinant Proteins; RNA, Messenger; Transcription, Genetic; Transfection | 1996 |
Blocking effect of anti-mouse interleukin-6 monoclonal antibody and glucocorticoid receptor antagonist, RU38486, on metallothionein-inducing activity of serum from lipopolysaccharide-treated mice.
Topics: Analysis of Variance; Animals; Antibodies, Monoclonal; Antidotes; Blood Proteins; Carcinoma, Hepatocellular; Cell Line; Charcoal; Corticosterone; Fluorometry; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Interleukin-6; Lipopolysaccharides; Liver; Liver Neoplasms; Male; Metallothionein; Mice; Mifepristone; Protein Binding; Receptors, Glucocorticoid; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1996 |
Cell-specific, promoter-dependent mineralocorticoid agonist activity of spironolactone.
Topics: Aldosterone; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Humans; Mifepristone; Promoter Regions, Genetic; Spironolactone; Tumor Cells, Cultured | 1997 |
Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor.
Topics: Animals; Binding, Competitive; Carcinoma, Hepatocellular; Cell Division; Dexamethasone; Ginsenosides; Glucocorticoids; Ligands; Mifepristone; Panax; Plants, Medicinal; Rats; Receptors, Glucocorticoid; Recombinant Fusion Proteins; Saponins; Transcriptional Activation; Tumor Cells, Cultured | 1997 |
The glucocorticoid receptor regulates the binding of C/EPBbeta on the alpha-1-acid glycoprotein promoter in vivo.
Topics: Adrenal Gland Neoplasms; Animals; Base Sequence; Binding Sites; Carcinoma, Hepatocellular; CCAAT-Enhancer-Binding Proteins; Chromatin; Deoxyribonuclease I; Dexamethasone; DNA Footprinting; DNA-Binding Proteins; Hormone Antagonists; Mifepristone; Molecular Sequence Data; Mutation; Nuclear Proteins; Orosomucoid; Polymerase Chain Reaction; Promoter Regions, Genetic; Rats; Receptors, Glucocorticoid; Transcription, Genetic; Tumor Cells, Cultured | 1997 |
Estrogen-induced hepatic toxicity and hepatic cancer: differences between two closely related hamster species.
Topics: Adenoma, Liver Cell; Animals; Bilirubin; Carcinoma, Hepatocellular; Cricetinae; Cricetulus; Diethylstilbestrol; Estrogens; Female; Inclusion Bodies; Liver; Liver Neoplasms, Experimental; Male; Medroxyprogesterone Acetate; Mifepristone; Species Specificity; Tamoxifen; Zeranol | 1998 |
A reporter gene assay to assess the molecular mechanisms of xenobiotic-dependent induction of the human CYP3A4 gene in vitro.
Topics: Alkaline Phosphatase; beta-Naphthoflavone; Caffeine; Carbamazepine; Carcinoma, Hepatocellular; Clofibrate; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dexamethasone; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gene Expression Regulation; Genes, Reporter; Glucocorticoids; Hormone Antagonists; Humans; Isoniazid; Mifepristone; Mixed Function Oxygenases; Phenobarbital; Phenylbutazone; Phenytoin; Receptors, Glucocorticoid; Recombinant Proteins; Rifampin; Tumor Cells, Cultured; Xenobiotics | 1999 |